Korean Pharma Asks For Govt Support as MERS Hits Sales
This article was originally published in PharmAsia News
Executive Summary
South Korean pharma firms have decided to ask the government to support the industry, which is suffering from sales decline due to the recent outbreak of the Middle East Respiratory Syndrome (MERS) coronavirus. They will ask the government to postpone a planned drug price cut by one year in an effort to overcome the MERS impact and proceed with drug development and globalization programs.